240 related articles for article (PubMed ID: 24158229)
21. A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important?
Nikolic D; Banach M; Nikfar S; Salari P; Mikhailidis DP; Toth PP; Abdollahi M; Ray KK; Pencina MJ; Malyszko J; Rysz J; Rizzo M;
Int J Cardiol; 2013 Oct; 168(6):5437-47. PubMed ID: 24016544
[TBL] [Abstract][Full Text] [Related]
22. [Statins: what is their place in the treatment of chronic kidney insufficiency?].
Ponte B; Bourquin V; Stoermann-Chopard C
Rev Med Suisse; 2009 Feb; 5(192):463-4, 466-8. PubMed ID: 19317313
[TBL] [Abstract][Full Text] [Related]
23. Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence.
Kanbay M; Turgut F; Covic A; Goldsmith D
J Nephrol; 2009; 22(5):598-609. PubMed ID: 19809992
[TBL] [Abstract][Full Text] [Related]
24. Effects of Statins on Renal Outcome in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis.
Sanguankeo A; Upala S; Cheungpasitporn W; Ungprasert P; Knight EL
PLoS One; 2015; 10(7):e0132970. PubMed ID: 26151753
[TBL] [Abstract][Full Text] [Related]
25. Statins for treatment of dyslipidemia in chronic kidney disease.
Shurraw S; Tonelli M
Perit Dial Int; 2006; 26(5):523-39. PubMed ID: 16973506
[TBL] [Abstract][Full Text] [Related]
26. The lipid story in chronic kidney disease: a long story with a happy end?
Kujawa-Szewieczek A; Więcek A; Piecha G
Int Urol Nephrol; 2013 Oct; 45(5):1273-87. PubMed ID: 23054316
[TBL] [Abstract][Full Text] [Related]
27. [USE OF STATINS IN PATIENTS WITH CHRONIC KIDNEY DISEASE TO PREVENT CARDIOVASCULAR DISEASE].
Zavidić T; Lodeta B; Lovrinić Đ
Acta Med Croatica; 2016 Dec; 70(4-5):301-7. PubMed ID: 29087163
[TBL] [Abstract][Full Text] [Related]
28. Chronic kidney disease and statins: improving cardiovascular outcomes.
Walker DB; Walker TJ; Jacobson TA
Curr Atheroscler Rep; 2009 Jul; 11(4):301-8. PubMed ID: 19500494
[TBL] [Abstract][Full Text] [Related]
29. [Effects of statins on delaying progression of chronic kidney disease: a meta-analysis].
Liu ZR; Zhao H; Chen YR; Tang DD; Niu HX
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 36(4):445-54. PubMed ID: 27113168
[TBL] [Abstract][Full Text] [Related]
30. [Chronic kidney disease and statins].
Matovinović MS
Lijec Vjesn; 2006; 128(11-12):345-50. PubMed ID: 17212196
[TBL] [Abstract][Full Text] [Related]
31. HMG CoA reductase inhibitors (statins) for dialysis patients.
Navaneethan SD; Nigwekar SU; Perkovic V; Johnson DW; Craig JC; Strippoli GF
Cochrane Database Syst Rev; 2009 Jul; (3):CD004289. PubMed ID: 19588351
[TBL] [Abstract][Full Text] [Related]
32. Impact of Chronic Kidney Disease on Risk for Vascular Events.
Fan J; Salameh H
Curr Vasc Pharmacol; 2016; 14(5):409-414. PubMed ID: 27456102
[TBL] [Abstract][Full Text] [Related]
33. Association between intensity of statin therapy and mortality in persons with chronic kidney disease.
Walther CP; Richardson PA; Virani SS; Winkelmayer WC; Navaneethan SD
Nephrol Dial Transplant; 2020 Feb; 35(2):312-319. PubMed ID: 30053252
[TBL] [Abstract][Full Text] [Related]
34. Nonstatin therapies for management of dyslipidemia: a review.
Sando KR; Knight M
Clin Ther; 2015 Oct; 37(10):2153-79. PubMed ID: 26412799
[TBL] [Abstract][Full Text] [Related]
35. Ezetimibe as a potential treatment for dyslipidemia associated with chronic renal failure and renal transplant.
Ahmed MH; Khalil AA
Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1021-9. PubMed ID: 21060168
[TBL] [Abstract][Full Text] [Related]
36. Effects of statins on renal function.
Agarwal R
Mayo Clin Proc; 2007 Nov; 82(11):1381-90. PubMed ID: 17976359
[TBL] [Abstract][Full Text] [Related]
37. Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?
Athyros VG; Katsiki N; Karagiannis A; Mikhailidis DP
Expert Opin Pharmacother; 2015; 16(10):1449-61. PubMed ID: 26037614
[TBL] [Abstract][Full Text] [Related]
38. [Use of statins for preventing cardiovascular and renal outcomes in patients with chronic kidney disease excluding dialysis: guideline from the Italian Society of Nephrology].
De Nicola L; Strippoli GF; Ravani P; Del Vecchio L; Cianciaruso B;
G Ital Nefrol; 2007; 24 Suppl 37():S83-90. PubMed ID: 17347957
[TBL] [Abstract][Full Text] [Related]
39. Statins in patients with chronic kidney disease: new evidence.
Savino M; Garofalo C; De Paris V; Michini C; Pirro L; Palmisano R; Provenzano M; Minutolo R; Conte G; De Nicola L
Minerva Urol Nefrol; 2013 Sep; 65(3):217-23. PubMed ID: 23872633
[TBL] [Abstract][Full Text] [Related]
40. Dyslipidemia and progression of kidney disease: role of lipid-lowering drugs.
Campese VM
Clin Exp Nephrol; 2014 Apr; 18(2):291-5. PubMed ID: 24535025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
